Salute e Benessere

ONWARD Medical Receives FDA 510(k) Clearance Expanding ARC-EX System Indication…

THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE 7(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596/2014)US FDA clearance now allows use of the ARC-EX ®System both in clinicsandhomesARC-EX is the first and only FDA-cleared technology demonstrated to improve hand strength and sensation in people with spinal cord injuryYear to date, ARC-EX Systems have been purchased by more than 60 US clinics EINDHOVEN, the Netherlands, Nov.17, 2025...
Nasdaq GlobeNewswire
17/11/2025

CFO Tania Micki to leave Tecan for new role in 2026

Ad hoc announcement pursuant to Article 53 of the SIX Exchange Regulation Listing Rules Männedorf, Switzerland, November 17, 2025 –The Tecan Group (SIX Swiss Exchange: TECN) today announced that Tania Micki, Chief Financial Officer and member of the Management Board since February 2020, will be leaving the company to pursue an external opportunity. She will continue in her role through May 2026 to ensure a smooth transition. Tecan will nominate her successor in due time, leveraging...
Nasdaq GlobeNewswire
17/11/2025

LG DEBUTS SKS CHICAGO SHOWROOM, OFFERING AN IMMERSIVE LUXURY LIFESTYLE…

The SKS Chicago Showroom is an innovation hub where visitors can experience SKS's "True to Food" philosophy and advanced technologies in an immersive, lifestyle-oriented setting. Located inside THE MART (formerly the Merchandise Mart) – one of North America's premier destinations for kitchen and interior design professionals – the showroom helps designers, builders and consumers imagine how the latest SKS solutions can enrich modern living with style and simplicity. The SKS Chicago…
PR Newswire
17/11/2025

China's Dialysis Industry Leader to Showcase Cutting-Edge Solutions at MEDICA…

At MEDICA, visitors will have the opportunity to explore the SWS's comprehensive product portfolio, designed to improve treatment outcomes and workflow efficiency. Highlights include: At MEDICA, visitors will have the opportunity to explore the SWS's comprehensive product portfolio, designed to improve treatment outcomes and workflow efficiency. Highlights include: Based inChongqing, SWS Medical, is a prominent global provider of innovative medical products and services. Its offerings...
PR Newswire
17/11/2025

Fotona Appoints Aimee Desrosiers as Global Chief Marketing Officer

Prior to that, Desrosiers has also held senior leadership roles including Chief Revenue Officer & President of Medical Aesthetics at The SEES Group, Chief Marketing Officer at Nvision, and Senior Vice President with Masco Coatings. In these roles, she built scalable consumer and professional marketing models, introduced digital and direct-to-consumer programs, and drove sustained revenue and brand growth across competitive healthcare markets. Prior to that, Desrosiers has also held senior...
PR Newswire
16/11/2025

Biogen Completes Acquisition of Alcyone Therapeutics

Biogen Inc. (Nasdaq: BIIB) has completed the acquisition of Alcyone Therapeutics, a clinical-stage biotechnology company known for its innovative CNS therapy delivery solutions, such as the ThecaFlex DRx™ drug delivery system.ThecaFlex DRx™ is an investigational implantable device designed to provide an alternative to repeat lumbar punctures in chronic intrathecal administration of medicines, which could ease both patient experience and accessibility for a broader population of people...
Nasdaq GlobeNewswire
14/11/2025

CROSSJECT completes €5 million financing with Vatel Capital

Press releaseCROSSJECTcompletes €5 million financing with Vatel CapitalDIJON, France – November 14th, 2025 (8.30 PM CET) –CROSSJECT (ISIN: FR0011716265; Euronext: ALCJ), a specialty pharmaceuticals company that develops products for emergency situations based on its proprietary ZENEO® needle-free auto-injector technology, in the advanced stages of development and registration of ZEPIZURE®, an injectable for the treatment of epileptic seizures, today announces the completion of a...
Nasdaq GlobeNewswire
14/11/2025

Positioning Barbados as the Caribbean’s Life Sciences Hub

EarlyHealth City to Anchor US$200 Million Investment Located across 45 acres, EarlyHealth City will feature three domes totaling more than 250,000 square feet of contract manufacturing space dedicated to the production of oral solids, semi-solids, liquids, and advanced biologics. This includes integrated capabilities for cell cultivation, upstream and downstream bioprocessing, and full scale-up to commercial release under United States and European Union Good Manufacturing Practice (GMP)...
Nasdaq GlobeNewswire
14/11/2025

Fagron completes share buy-back program

Regulated information Nazareth (Belgium)/Rotterdam (The Netherlands), 14 November 2025 – 6PM CET Fagron completes share buy-back program In the period from 10 November 2025 through 14 November 2025, Fagron purchased 44,000 of its owns shares at an average price of €20.7208 per share corresponding to a total amount of €911,717.00. A total of 200,000 Fagron shares have been repurchased under the buy-back program at an average price of € 20.6805 per share, corresponding to a total amount of...
Nasdaq GlobeNewswire
14/11/2025

SEQUANA MEDICAL ANNOUNCES NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES

SEQUANA MEDICAL ANNOUNCES NEW SHARE CAPITAL AMOUNTAND NEW NUMBER OF SHARES PRESS RELEASE REGULATED INFORMATION 14 November 2025, 6:00 pm CETGhent, Belgium, 14 November 2025 – Sequana Medical NV(Euronext Brussels: SEQUA)(the " Company " or " SequanaMedical "), a pioneer in the treatment of drug-resistant fluid overload in liver disease, heart failure and cancer, announces today that, as a result of a subscription to new shares by GEM Global Yield LLC SCS (" GEM...
Nasdaq GlobeNewswire
14/11/2025

SeriousFun Children's Network Appoints Denise Bailey-Castro and Camilla Castro…

"Denise and Camilla bring exceptional leadership experience and a shared passion for empowering young people," said Blake Maher, CEO of SeriousFun Children's Network. "Their strategic insight and commitment to children facing health challenges will strengthen our mission and the lasting impact we deliver to children around the world." "Denise and Camilla bring exceptional leadership experience and a shared passion for empowering young people," said Blake Maher , CEO…
PR Newswire
14/11/2025

Cornerstone Robotics Closes Oversubscribed New Financing Round of Approximately…

With its industry-leading technologies and strong growth potential in the field of surgical robotics, Cornerstone Robotics has attracted a global strategic investor in this financing round. The Company also welcomed some global institutional or sovereign wealth funds, whose participation will further support Cornerstone Robotics' market access and strategic partnerships globally. Existing shareholders have also increased their investment, reaffirming their strong confidence in the Company's…
PR Newswire
14/11/2025

Fondazione Telethon announces CHMP positive opinion for Waskyra™, a gene therapy…

Developed through decades of research at theSan Raffaele Telethon Institute for Gene Therapy (SR-Tiget)inMilan, the therapy represents a major scientific and clinical achievement, offering new hope for patients affected by this condition. "This milestone demonstrates that academic research, when guided by a strong sense of responsibility towards patients and conducted to the highest industrial standards, can truly change the natural history of rare diseases," said Ilaria...
PR Newswire
14/11/2025

Medical Device Plastics Market worth $31.82 billion by 2030 - Exclusive Report…

220 - Tables90 - Figures255 - Pages 220 - Tables 90 - Figures 255 - Pages Download PDF Brochure:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=122410426 The growth of the medical device plastics market is being propelled by a combination of technological, demographic, and regional factors. Global healthcare spending, expanding medical device manufacturing base, and rapid adoption of advanced, diagnostic, and therapeutic technologies are driving consistent demand for...
PR Newswire
14/11/2025

Cardiovascular Biologics Market Expected to Reach USD 4.23 Billion by 2033 Amid…

Growth Drivers: Innovation Meets Unmet Clinical Need Growth Drivers: Innovation Meets Unmet Clinical Need Download PDF Brochure:https://www.datamintelligence.com/download-sample/cardiovascular-biologics-market Browse in-depth TOC on "Cardiovascular Biologics Market" 70 – Tables 66 – Figures 195 – Pages Market Segmentation Analysis By Biologic Type The market is categorized intoMonoclonal Antibodies (mAbs),siRNA-Based Therapeutics,Recombinant Proteins...
PR Newswire
14/11/2025

Resolutions from the Extraordinary General Meeting of Novo Nordisk A/S

Bagsværd, Denmark, 14 November 2025 - Today, Novo Nordisk A/S held its Extraordinary General Meeting, which was convened to elect new members of the Board of Directors.At the Extraordinary General Meeting, Helge Lund (chair), Henrik Poulsen (vice chair) and the Board members Laurence Debroux, Andreas Fibig, Sylvie Grégoire, Christina Law and Martin Mackay stepped down from the Board of Directors. Resolutions adopted at the Extraordinary General Meeting ElectionsElection of Lars...
Nasdaq GlobeNewswire
14/11/2025

Alkermes Response to Avadel Announcement

Terms used but not defined in this announcement have the same meaning given to them in the Transaction Agreement entered into between Alkermes and Avadel (the "Transaction Agreement") and the related Rule 2.7 Announcement under the Irish Takeover Rules. Terms used but not defined in this announcement have the same meaning given to them in the Transaction Agreement entered into between Alkermes and Avadel (the "Transaction Agreement") and the related Rule 2.7 Announcement…
PR Newswire
14/11/2025

Press Release: Sanofi’s Teizeild recommended for EU approval by the CHMP for…

Sanofi’s Teizeild recommended for EU approval by the CHMP for patients with stage 2 type 1 diabetesRecommendation based on the TN-10 study, demonstrating Teizeild’s ability to delay the onset of stage 3 type 1 diabetes (T1D), compared to placebo, in adults and children with stage 2 T1DIf approved, Teizeild would become the first disease-modifying T1D therapy in the EU Paris,November 14,2025.The European Medicines Agency (EMA)’s Committee for Medicinal Products for Human Use...
Nasdaq GlobeNewswire
14/11/2025

Orion receives award for international growth from the President of the Republic…

ORION CORPORATIONPRESS RELEASE14 NOVEMBER 2025 at 13.30 EET Orion receives award for international growth from the President of the Republic of FinlandToday, the President of the Republic of Finland,Alexander Stubb, has awarded Orion Corporation the Internationalisation Award of the President in the growth companies category.The Internationalisation Awards of the President of the Republic of Finland are bestowed annually in recognition of internationally successful...
Nasdaq GlobeNewswire
14/11/2025

Mom's Garden Showcases at CIIE, Gaining Traction in Chinese Market

"We are incredibly impressed by Chinese consumers' focus on clinically-proven evidence and high standards for quality," said Olga Stepanko, Global Brand Manager at Mom's Garden. "The CIIE is a great platform for connecting Germany's scientific expertise with the specific demands of the Chinese market. We look forward to expanding collaboration in health and nutrition to deliver product innovation grounded in solid scientific research." "We are incredibly impressed by…
PR Newswire
14/11/2025

Lundbeck files for marketing authorization across key Asian markets for Vyepti®…

"The acceptance of these regulatory applications signifies a critical milestone in Lundbeck's Asian development program for eptinezumab." said Johan Luthman, EVP and Head of Research and Development at Lundbeck. "Eptinezumab has the potential to fulfil a significant unmet need in Asia, where migraine preventive treatments remain underutilized. The eptinezumab global roll-out also paves the way for advancing additional migraine and neuro-rare programs to patients." "The…
PR Newswire
14/11/2025

Medicxi Announces €500 Million Fund V

Medicxi has created 16 new companies, delivered over 20 positive clinical data readouts and has realised over $1 billion across its portfolio since its last fundraise, including from investments in Vaxcyte, Merus and Abivax, and the acquisitions of ViceBio (Sanofi), Versanis Bio (Eli Lilly) and ProfoundBio (Genmab). Medicxi has created 16 new companies, delivered over 20 positive clinical data readouts and has realised over$1 billionacross its portfolio since its last fundraise, including...
PR Newswire
14/11/2025

Lumenis Launches OptiLIFT, a New Dynamic Muscle Stimulation Device, in the U.K.

Lower lid laxity is highly prevalent and is associated with the natural aging process, caused in part by the weakening of the orbicularis oculi muscle (OOM).1 Skeletal muscles lose 3-8% mass each decade after age 30.1 Muscle weakening in the periorbital area reduces structural support, which can result in lower lid laxity and incomplete blinking, leading to ocular symptoms and aesthetic concerns.2,3,4 One study revealed that more than 60% of dry eye patients suffer from impaired lid closure. ...
PR Newswire
14/11/2025

Diamyd Medical's pivotal Phase 3 Type 1 Diabetes trial clears last safety review…

"The continued favorable safety profile demonstrated in DIAGNODE-3 and earlier studies reinforces Diamyd's position as a leading precision medicine candidate in Type 1 Diabetes," says Professor Johnny Ludvigsson, Coordinating Investigator of DIAGNODE-3. "The continued favorable safety profile demonstrated in DIAGNODE-3 and earlier studies reinforces Diamyd's position as a leading precision medicine candidate in Type 1 Diabetes," says ProfessorJohnny Ludvigsson, Coordinating…
PR Newswire
14/11/2025
Altri  Comunicati